Streetbeat News

Legal

AAPL

EIRL

The Irish Finance Minister has stated that it is not possible to comment on whether other countries might claim a portion of Apple's back taxes. This situation remains uncertain and could impact Apple's financial obligations.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:34 pm

AZN

AstraZeneca is under investigation by Chinese authorities for potential data privacy breaches and unlicensed drug importation. CEO Pascal Soriot assures compliance and cooperation. Meanwhile, AstraZeneca's lung cancer drug trial shows promising but not statistically significant results.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 1:19 pm

ALIM

ANIP

Alimera Sciences shares declined following the company's announcement of a lawsuit against ANI Pharmaceuticals, related to fulfilling a contractual obligation for a merger agreement.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:15 pm

AAPL

The European Court of Justice (ECJ) has overturned a 2020 judgment, confirming the European Commission's 2016 state aid decision against Apple. As a result, Apple expects to incur a one-time income tax charge of up to $10 billion in Q4, impacting its effective tax rate.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:13 pm

KDP

The U.S. SEC has charged Keurig with making inaccurate statements about the recyclability of its K-cup beverage pods. This legal action could impact Keurig's parent company, Keurig Dr Pepper (KDP), by affecting its reputation and potentially leading to financial penalties.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:03 pm

ALIM

ANIP

Alimera Sciences has filed a lawsuit against ANI Pharmaceuticals in the Delaware Court of Chancery to compel ANI to fulfill its contractual obligations and close their merger agreement. Alimera's shareholders approved the merger on September 4, clearing the last requirement for closing.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:02 pm

JNJ

KVUE

Kenvue Inc. (NYSE:KVUE) is showing a bullish pattern with a potential Golden Cross on its stock chart, indicating a possible upward move. The company recently won a legal case regarding its Tylenol 'Rapid Release' gelcaps, adding to its positive momentum. Kenvue's strong brand portfolio and recent stock performance suggest continued bullish sentiment.

Portfolio Pulse from Surbhi Jain

September 10, 2024 | 12:48 pm

BP

MCD

NSC

Norfolk Southern CEO Alan Shaw is expected to step down amid an ethics investigation into an alleged relationship with an employee. His tenure faced challenges, including a train derailment and criticism from activist investors. The trend of executive dismissals over ethics violations is growing.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 12:34 pm

HOOD

FTX has filed a motion to settle a dispute over $600 million worth of Robinhood shares by paying $14 million to Emergent Fidelity Technologies. This settlement aims to resolve Emergent's bankruptcy case and facilitate FTX's reorganization efforts. The court will review the motion on October 22.

Portfolio Pulse from Murtuza Merchant

September 10, 2024 | 12:28 pm

RDY

Dr. Reddy's Laboratories has clarified allegations regarding its engagement with Agora Advisory, confirming the engagement of Dhaval Buch from October 2020 to April 2021, before Madhabi Buch became SEBI Chairperson. The company asserts compliance with laws and denies any preferential treatment by SEBI.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:15 pm